Related Experiment Videos
A protein kinase system from platelet rich plasma
Biochemical and Biophysical Research Communications
|June 15, 1983
Summary
Platelet-rich plasma (PRP) contains a novel protein kinase system that phosphorylates plasma proteins, including fibrinogen. This kinase activity is enhanced by Mn2+ and inhibited by ADP.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Platelet-rich plasma (PRP) is a concentrate of platelets in a small volume of plasma.
- Platelets play a crucial role in hemostasis and thrombosis.
- Protein phosphorylation is a key regulatory mechanism in cellular processes.
Purpose of the Study:
- To characterize a protein kinase system present in platelet-rich plasma.
- To identify the substrates and regulatory properties of this kinase.
Main Methods:
- Treatment of PRP at pH 5 to precipitate the protein kinase system.
- Phosphorylation of plasma proteins using 32P-labeled ATP.
- Analysis of phosphoproteins by two-dimensional gel electrophoresis.
- Enzyme activity assays to determine substrate specificity and inhibitor effects.
Main Results:
- A protein kinase system was isolated from PRP, associated with the platelet fraction.
- The kinase phosphorylates three major proteins: 72K (identified as fibrinogen alpha-chain), 80K, and another 72K protein.
- Kinase activity is enhanced by Mn2+, phosphorylates histone, and is independent of cAMP/cGMP.
- ADP competitively inhibits the kinase activity.
Conclusions:
- PRP contains a distinct protein kinase capable of phosphorylating plasma proteins, including fibrinogen.
- The kinase exhibits specific substrate preferences and regulatory properties.
- Further research is needed to identify the remaining phosphoprotein substrates.